Citigroup reaffirmed a neutral rating on AvePoint, and insider transactions involving the company were disclosed to the SEC.

The entities involved

• Citigroup →

  American investment bank and financial services corporation

  • Cantor Fitzgerald and Citigroup restated positive rating upgrades for Sagimet Biosciences.11:38
  • Financial institutions, including Citigroup and RBC, filed 13F reports and adjusted analyst ratings with the SEC.11:34
• AvePoint →

  American software vendor

  • MarketBeat provided analyst ratings and financial comparisons for technology companies Fortinet and AvePoint.01:31
• SEC →

  Slovak company

  • Gap Inc. filed with the SEC regarding institutional investment activity, and Jefferies downgraded its stock rating and target price.11:56
  • A director of Immunome, Inc. sold company stock on July 2, 2026, disclosing the transaction to the SEC.11:35

Related events

• Citigroup reiterated a neutral rating on Norfolk Southern stock, while JPMorgan Chase & Co. issued a price target report.Oct 23
• Citigroup restated a neutral rating on Rapid7 shares, and Scotiabank upped its price target for the company.Sep 22
• Bank of America updated its price objective and rating, while Citigroup reissued a neutral rating on Biogen shares.Wed 12:15
• Citigroup reissued a neutral rating on Man Group, a company headquartered in London.Jul 11
• Insider transaction disclosed in SEC filing concerning NexPoint Residential Trust on October 1, 2026.Oct 6